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Background
Semen is the main vector for HIV-1 dissemination world-
wide. It contains three major sources of infectious virus:
free virions, infected leukocytes, and spermatozoa-associ-
ated virions. In this study we focused on the interaction of
HIV-1 with human spermatozoa and the ability of sper-
matozoa to transmit the virus to dendritic cells (DCs).
Methods
Spermatozoa purified from healthy subjects were incu-
bated with HIV-1 BaL, IIIB or different strains from pri-
mary isolates, then washed to remove free virus, and the
amount of HIV associated to spermatozoa as well as the
ability of spermatozoa to transmit the virus to monocyte-
derived DCs was analyzed by measuring p24 antigen by
ELISA.
Results
Flow cytometry showed that heparan sulfate is expressed
in spermatozoa. Heparan sulfate plays an important role
in the capture of HIV-1, as demonstrated by the inhibitory
effect induced by heparine (50 U/ml) (>70% capture inhi-
bition, n = 15) and heparinase II pre-treatment of the
spermatozoa (>50% capture inhibition, n = 6). By con-
trast, treatment with the inhibitor of mannose receptor
mannan (5 mg/ml) slightly inhibited virus attachment (>
20% capture inhibition, n = 10). Spermatozoa-attached
viruses were efficiently transmitted to DCs through a cell-
to-cell contact-dependent mechanism. Fluorescence, con-
focal and electronic microscopy showed that this process
was associated to the internalization of a fraction of the
spermatozoa. This interaction also resulted in the pheno-
typic maturation of DCs (up-regulation of CD80, CD86,
CD40, CD83 and CCR7), and the production of IL-10 but
not IL-12p70. Finally, we found that acidic extracellular
pH levels, similar to those found in the vaginal mucosa
after sexual intercourse, increased more than four times (n
= 12) the binding of HIV-1 to the spermatozoa and the
subsequent transmission of HIV-1 to DCs.
Conclusion
Our observations support the notion that far from being a
passive carrier, spermatozoa acting in concert with DCs
might affect the early course of sexual transmission of
HIV-1 infection.
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